The DOI matches its Crossref record; 37 of the 37 references it cites were found in a registry or an index.
Blockers of sodium and calcium entry protect axons from nitric oxide‐mediated degeneration
Abstract
Axonal degeneration can be an important cause of permanent disability in neurological disorders in which inflammation is prominent, including multiple sclerosis and Guillain–Barré syndrome. The mechanisms responsible for the degeneration remain unclear, but it is likely that axons succumb to factors produced at the site of inflammation, such as nitric oxide (NO). We previously have shown that axons exposed to NO in vivo can undergo degeneration, especially if the axons are electrically active during NO exposure. The axons may degenerate because NO can inhibit mitochondrial respiration, leading to intraaxonal accumulation of Na+ and Ca 2+ ions. Here, we show that axons can be protected from NO‐mediated damage using low concentrations of Na+ channel blockers, or an inhibitor of Na+/Ca 2+ exchange. Our findings suggest a new strategy for axonal protection in an inflammatory environment, which may be effective in preventing the accumulation of permanent disability in patients with neuroinflammatory disorders. Ann Neurol 2003
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Axonal transection in the lesions of multiple sclerosis
Trapp, B. D., Peterson, J., Ransohoff, R. M., Rudick, R., Mörk, S., & Bö, L. (1998) · New England Journal of Medicine · doi:10.1056/nejm199801293380502 · Cited by 4,029
Ebers, G. C. (1998) · The Lancet · doi:10.1016/s0140-6736(98)03334-0 · Cited by 2,073
Paty, D. W., Li, D. K. B., the UBC MS/MRI Study Group, & the IFNB Multiple Sclerosis Study Group (1993) · Neurology · doi:10.1212/wnl.43.4.662 · Cited by 1,967
Axonal damage in acute multiple sclerosis lesions
Ferguson, B. (1997) · Brain · doi:10.1093/brain/120.3.393 · Cited by 1,532
Amiloride and its analogs as tools in the study of ion transport
Kleyman, T. R., & Cragoe, E. J. (1988) · The Journal of Membrane Biology · doi:10.1007/bf01871102 · Cited by 1,140
Kappos, L. (1998) · The Lancet · doi:10.1016/s0140-6736(98)10039-9 · Cited by 936
Multiple Sclerosis and Chronic Autoimmune Encephalomyelitis
Kornek, B., Storch, M. K., Weissert, R., Wallstroem, E., Stefferl, A., Olsson, T., Linington, C., Schmidbauer, M., & Lassmann, H. (2000) · The American Journal of Pathology · doi:10.1016/s0002-9440(10)64537-3 · Cited by 921
Endogenous nitric oxide release required for long-term synaptic depression in the cerebellum
Shibuki, K., & Okada, D. (1991) · Nature · doi:10.1038/349326a0 · Cited by 871
Oxidative Stress in Brain Ischemia
Love, S. (1999) · Brain Pathology · doi:10.1111/j.1750-3639.1999.tb00214.x · Cited by 685
Stys, P., Waxman, S., & Ransom, B. (1992) · The Journal of Neuroscience · doi:10.1523/jneurosci.12-02-00430.1992 · Cited by 662
Cited by
Gold, R. (2006) · Brain · doi:10.1093/brain/awl075 · Cited by 1,017
“aberrantly expressed ion channels may indeed result in axonal damage in EAE, as axonal loss is significantly reduced by pharmacological agents that reduce sodium and calcium transport/entry across the axolemma (Kapoor et al., 2003; Bechtold et al., 2004).”
BackgroundMitochondrial dysfunction as a cause of axonal degeneration in multiple sclerosis patients
Dutta, R., McDonough, J., Yin, X., Peterson, J., Chang, A., Torres, T., Gudz, T., Macklin, W. B., Lewis, D. A., Fox, R. J., et al. (2006) · Annals of Neurology · doi:10.1002/ana.20736 · Cited by 841
Axon degeneration mechanisms: Commonality amid diversity
Coleman, M. (2005) · Nature reviews. Neuroscience · doi:10.1038/nrn1788 · Cited by 819
A reversible form of axon damage in experimental autoimmune encephalomyelitis and multiple sclerosis
Nikić, I., Merkler, D., Sorbara, C., Brinkoetter, M., Kreutzfeldt, M., Bareyre, F. M., Brück, W., Bishop, D., Misgeld, T., & Kerschensteiner, M. (2011) · Nature Medicine · doi:10.1038/nm.2324 · Cited by 713
“ROS and RNS fulfill these requirements and have been implicated in axon degeneratio”
BackgroundVirtual hypoxia and chronic necrosis of demyelinated axons in multiple sclerosis
Trapp, B. D., & Stys, P. K. (2009) · The Lancet Neurology · doi:10.1016/s1474-4422(09)70043-2 · Cited by 621
Gain of function Na V 1.7 mutations in idiopathic small fiber neuropathy
Faber, C. G., Hoeijmakers, J. G. J., Ahn, H., Cheng, X., Han, C., Choi, J., Estacion, M., Lauria, G., Vanhoutte, E. K., Gerrits, M. M., et al. (2012) · Annals of Neurology · doi:10.1002/ana.22485 · Cited by 557
Grey matter pathology in multiple sclerosis
Geurts, J. J., & Barkhof, F. (2008) · The Lancet Neurology · doi:10.1016/s1474-4422(08)70191-1 · Cited by 507
Coles, A. J., Cox, A., Page, E., Jones, J., Trip, S. A., Deans, J., Seaman, S., Miller, D. H., Hale, G., Waldmann, H., et al. (2006) · Journal of Neurology · doi:10.1007/s00415-005-0934-5 · Cited by 506
Axonal damage: a key predictor of outcome in human CNS diseases
Medana, I. M., & Esiri, M. M. (2003) · Brain · doi:10.1093/brain/awg061 · Cited by 464
Craner, M. J., Newcombe, J., Black, J. A., Hartle, C., Cuzner, M. L., & Waxman, S. G. (2004) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0402765101 · Cited by 446
Pathogenesis of axonal and neuronal damage in multiple sclerosis
Dutta, R., & Trapp, B. D. (2007) · Neurology · doi:10.1212/01.wnl.0000275229.13012.32 · Cited by 412
Mitochondrial defects in acute multiple sclerosis lesions
Mahad, D., Ziabreva, I., Lassmann, H., & Turnbull, D. (2008) · Brain · doi:10.1093/brain/awn105 · Cited by 406
“The demyelinated axons can be protected from NO mediated degeneration, which involves an energy deficient state, using Na+ channel blockers or inhibitors of Na+/Ca2+ exchanger (Garthwaite et al., 2002; Kapoor et al., 2003).”
BackgroundAxonal conduction and injury in multiple sclerosis: the role of sodium channels
Waxman, S. G. (2006) · Nature Reviews Neuroscience · doi:10.1038/nrn2023 · Cited by 397
Neurological perspectives on voltage-gated sodium channels
Eijkelkamp, N., Linley, J. E., Baker, M. D., Minett, M. S., Cregg, R., Werdehausen, R., Rugiero, F., & Wood, J. N. (2012) · Brain · doi:10.1093/brain/aws225 · Cited by 359
Cannabinoids inhibit neurodegeneration in models of multiple sclerosis
Pryce, G., Ahmed, Z., Hankey, D. J. R., Jackson, S. J., Croxford, J. L., Pocock, J. M., Ledent, C., Petzold, A., Thompson, A. J., Giovannoni, G., et al. (2003) · Brain · doi:10.1093/brain/awg224 · Cited by 342
Astrocytes—Friends or foes in multiple sclerosis?
Williams, A., Piaton, G., & Lubetzki, C. (2007) · Glia · doi:10.1002/glia.20546 · Cited by 302
Cigarette smoking and the progression of multiple sclerosis
Hernán, M. A., Jick, S. S., Logroscino, G., Olek, M. J., Ascherio, A., & Jick, H. (2005) · Brain · doi:10.1093/brain/awh471 · Cited by 294
Inflammation, demyelination, and degeneration — Recent insights from MS pathology
Stadelmann, C., Wegner, C., & Brück, W. (2011) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/j.bbadis.2010.07.007 · Cited by 276
Neuroprotection and repair in multiple sclerosis
Franklin, R. J. M., ffrench-Constant, C., Edgar, J. M., & Smith, K. J. (2012) · Nature Reviews Neurology · doi:10.1038/nrneurol.2012.200 · Cited by 278
Self-citationKapoor, R., Furby, J., Hayton, T., Smith, K. J., Altmann, D. R., Brenner, R., Chataway, J., Hughes, R. A., & Miller, D. H. (2010) · The Lancet Neurology · doi:10.1016/s1474-4422(10)70131-9 · Cited by 268
Self-citationRiluzole, Neuroprotection and Amyotrophic Lateral Sclerosis
Cheah, B. C., Vucic, S., Krishnan, A., & Kiernan, M. C. (2010) · Current Medicinal Chemistry · doi:10.2174/092986710791163939 · Cited by 258
Irvine, K.-A., & Blakemore, W. F. (2006) · Journal of Neuroimmunology · doi:10.1016/j.jneuroim.2006.03.002 · Cited by 117
Axonal injury in multiple sclerosis
Lassmann, H. (2003) · Journal of Neurology, Neurosurgery & Psychiatry · doi:10.1136/jnnp.74.6.695 · Cited by 112
Warne, J., Pryce, G., Hill, J. M., Shi, X., Lennerås, F., Puentes, F., Kip, M., Hilditch, L., Walker, P., Simone, M. I., et al. (2016) · Journal of Biological Chemistry · doi:10.1074/jbc.m115.700385 · Cited by 99
“…16, 17), the PT pore-induced ATP deficit may result in the inactivation of energy-dependent sodium/potassium pumps, leading to sodium loading and the reversal of the sodium-calcium exchanger that causes toxic accumulation of calcium ions and the induction of cell death effector pathways (16, 18).”
Inflammation: good or bad for ADHD?
Donev, R., & Thome, J. (2010) · ADHD Attention Deficit and Hyperactivity Disorders · doi:10.1007/s12402-010-0038-7 · Cited by 54
Metadata
- Authors
- Kapoor, R., Davies, M., Blaker, P. A., Hall, S. M., & Smith, K. J.
- Venue
- Annals of Neurology
- Publisher
- Wiley
- Published
- 2002-12-30
- Volume
- 53
- Issue
- 2
- Pages
- 174-180
- ISSN
- 0364-5134 (ISSN-L)
- 1531-8249
- OpenAlex
- W1988771698
- Cited by
- 252
- References
- 37
- FWCI
- 6.07
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.